Exemple de utilizare a In vitro data în Engleză și traducerile lor în Română
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
In vitro data.
The clinical significance of these in vitro data has not been demonstrated.
In vitro data indicate that ruxolitinib may inhibit P-gp and BCRP.
Aureus exhibited natural in vitro resistance to cefovecin 4 The clinical significance of these in vitro data has not been demonstrated.
In vitro data demonstrate that cabozantinib is a substrate of MRP2.
Oamenii se traduc, de asemenea,
Based on in vitro data, a potential for GZR to inhibit BSEP cannot be excluded.
In vitro data suggests that netupitant inhibits the efflux of transporter BCRP.
In vitro data indicate that cinacalcet is in part metabolised by CYP1A2.
YK only has in vitro data on C2C12 cells from mice myoblast cell line capable of differentiation.
In vitro data indicate cobimetinib is not an inhibitor of OAT1, OAT3 or OCT2.
In vitro data indicate that sacubitril inhibits OATP1B1 and OATP1B3 transporters.
In vitro data showed a slight increase of resistance of C. glabrata to voriconazole.
In vitro data indicate that the following species are not susceptible to ceftaroline.
In vitro data indicate that the following species are not susceptible to ceftolozane/tazobactam.
In vitro data indicate that gefitinib is a substrate for the membrane transport protein Pgp.
In vitro data indicate that repaglinide is metabolised predominantly by CYP2C8, but also by CYP3A4.
In vitro data indicate that CYP2D6 and CYP3A4 contribute to the limited metabolism of alogliptin.
Based on in vitro data, at clinically relevant concentrations avanafil could be an inhibitor of BCRP.
In vitro data indicate that this is predominantly mediated by the cytochrome P450 3A4 isoform(CYP3A4).
Based on in vitro data, ceritinib is a substrate of the efflux transporter P-glycoprotein(P-gp).
In vitro data indicate that ulipristal acetate and its active metabolite are not P-gp(ABCB1) substrates.
Based on in vitro data pasireotide appears to be a substrate of efflux transporter P-gp(P-glycoprotein).
In vitro data indicate that IL-5 and reslizumab are unlikely to affect CYP1A2, 3A4 or 2B6 activity.
In vitro data indicate that ulipristal acetate may be an inhibitor of P-gp at clinically relevant concentrations.
Based on in vitro data, ceritinib also inhibits CYP2A6 and CYP2E1 at clinically relevant concentrations.
In vitro data indicate that ledipasvir may be a weak inducer of metabolising enzymes such as CYP3A4, CYP2C and UGT1A1.
Based on in vitro data, ceritinib is predicted to inhibit intestinal P-gp and BCRP at clinically relevant concentrations.
In vitro data indicate that ketoconazole is an inhibitor of CYP1A2 and does not significantly inhibit CYP 2A6 and 2E1.
There are in vitro data indicating that prednisone may give rise to enzyme induction which could reduce the.